A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT)
- PMID: 31637308
- PMCID: PMC6794749
- DOI: 10.1186/s41256-019-0121-3
A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT)
Abstract
Background: In the typical prevention of mother to child transmission (PMTCT) of HIV cascade of care discussion or analysis, the period of analysis begins at the first visit for antenatal care (ANC) for that pregnancy. This starting point is problematic for two reasons: (1) a large number of HIV-infected women are already on life-long antiretroviral therapy (ART) when presenting for ANC; and (2) women present to ANC at different gestational ages. The PMTCT ART Coverage Tool (PMTCT-ACT), which estimates the proportion of days covered (PDC) with ART, was developed to address each of these problems.
Methods: PDC is a preferred method to measure adherence to chronic medications, such as ART. For evaluating the PMTCT cascade of care, as indicated by PDC with ART over various time periods, a "starting point" based on a specific day before delivery must be defined that applies to all women (treatment experienced or naïve at the first ANC visit at any gestational age). Using the example of 168 days prior to delivery (24 weeks), PMTCT-ACT measures PDC with ART during that period. PMTCT-ACT is provided as a STATA do-file. Using an example dataset for two women (ID1 is treatment experienced; ID2 is treatment naïve), the details of each major portion of the tool (Parts 1-5) are presented. PMTCT-ACT along with the intermediate datasets created during the analysis are provided as supplemental files.
Conclusions: Evaluating the PMTCT cascade of care requires a standard definition of the follow-up period during pregnancy that applies to all HIV-infected pregnant women and a standard measure of adherence. PMTCT-ACT is a new tool that fits this purpose. PMTCT-ACT can also be easily adjusted to evaluate other ante- and post-natal periods (e.g., final 4 weeks, final 8 weeks, complete pregnancy period, initial 24 weeks postpartum, time periods consistent with infant HIV testing guidelines).
Keywords: Cascade of care; Coverage; HIV; Pill count; Pregnancy; Prevention of mother-to-child transmission; Proportion of days covered.
© The Author(s) 2019.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures
Similar articles
-
The effects of revised peer-counselor support on the PMTCT cascade of care: results from a cluster-randomized trial in Kenya (the EMMA study).BMC Infect Dis. 2023 Apr 25;23(1):257. doi: 10.1186/s12879-023-08246-4. BMC Infect Dis. 2023. PMID: 37098468 Free PMC article. Clinical Trial.
-
Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.Curr HIV Res. 2015;13(3):201-9. doi: 10.2174/1570162x1303150506183256. Curr HIV Res. 2015. PMID: 25986371 Free PMC article.
-
Increasing Proportion of HIV-Infected Pregnant Zambian Women Attending Antenatal Care Are Already on Antiretroviral Therapy (2010-2015).Front Public Health. 2019 Jun 13;7:155. doi: 10.3389/fpubh.2019.00155. eCollection 2019. Front Public Health. 2019. PMID: 31249826 Free PMC article.
-
Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.PLoS One. 2018 Aug 30;13(8):e0201955. doi: 10.1371/journal.pone.0201955. eCollection 2018. PLoS One. 2018. PMID: 30161147 Free PMC article.
-
Early retention among pregnant women on 'Option B + ' in urban and rural Zimbabwe.AIDS Res Ther. 2021 Apr 1;18(1):10. doi: 10.1186/s12981-021-00333-3. AIDS Res Ther. 2021. PMID: 33794957 Free PMC article. Review.
Cited by
-
The effects of revised peer-counselor support on the PMTCT cascade of care: results from a cluster-randomized trial in Kenya (the EMMA study).BMC Infect Dis. 2023 Apr 25;23(1):257. doi: 10.1186/s12879-023-08246-4. BMC Infect Dis. 2023. PMID: 37098468 Free PMC article. Clinical Trial.
-
Trends and effects of antiretroviral therapy coverage during pregnancy on mother-to-child transmission of HIV in Sub-Saharan Africa. Evidence from panel data analysis.BMC Infect Dis. 2022 Feb 8;22(1):134. doi: 10.1186/s12879-022-07119-6. BMC Infect Dis. 2022. PMID: 35135474 Free PMC article.
-
Over a decade of HIV infection prevalence and incidence among Mozambican pregnant women: a secondary analysis of prospectively collected data.BMC Public Health. 2025 Jan 21;25(1):251. doi: 10.1186/s12889-025-21467-3. BMC Public Health. 2025. PMID: 39838327 Free PMC article.
References
-
- WHO (World Health Organization). World health statistics 2017: monitoring health for the SDGs, Sustainable Development Goals. Geneva, Switzerland. Licence: CC BY-NC-SA 3.0 IGO.; 2017.
-
- WHO (World Health Organization). Prevention of mother-to-child transmission (PMTCT) Situation and trends. 2019.
-
- Vrazo AC, Firth J, Amzel A, Sedillo R, Ryan J, Phelps BR. Interventions to significantly improve service uptake and retention of HIV-positive pregnant women and HIV-exposed infants along the prevention of mother-to-child transmission continuum of care: systematic review. Trop Med Int Heal. 2018;23(2):136–148. doi: 10.1111/tmi.13014. - DOI - PubMed
-
- WHO (World Health Organization). Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update. Geneva, Switzerland; 2016. - PubMed
LinkOut - more resources
Full Text Sources
Medical